{"entity":{"type":"insider","cik":"0001280952","url":"/insider/0001280952","json_url":"/insider/0001280952.json","name":"SIGNET HEALTHCARE PARTNERS, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":4,"first":"2014-08-29","last":"2020-09-16","span_basis":"filed_date"},"name_variants":[{"name":"SIGNET HEALTHCARE PARTNERS, LLC","source":"filing","n_filings":2,"first_seen":"2015-03-06","last_seen":"2020-09-16"},{"name":"LOF PARTNERS LLC","source":"filing","n_filings":2,"first_seen":"2014-08-29","last_seen":"2014-09-04"}],"transactions":[{"id":2885827,"accession":"0001213900-20-027008","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001213900-20-027008","line_url":"/filing/0001213900-20-027008","is_derivative":false,"issuer_cik":"0000352998","issuer_name":"Teligent, Inc.","issuer_ticker":"TLGT","issuer_name_source":null,"issuer_url":"/issuer/0000352998","owner_cik":null,"owner_name":"MORRIS BEN T; GALE JAMES C; WEIR DONALD V; LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP; LIFE SCIENCES OPPORTUNITIES FUND II LP; SANDERS DON A; SIGNET HEALTHCARE PARTNERS, LLC","owner_display_name":"MORRIS BEN T","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":560618.0,"shares_display":"560,618","price_per_share":1.2441527721193397,"price_display":"1.24","price_state":"stated","total_value":697494.4388,"total_display":"697,494.44","total_whole":"697,494","shares_owned_after":98390.0,"shares_owned_after_display":"98,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-26","filed_date":"2020-09-16","scope":"insider","n_lines":2},{"id":2885818,"accession":"0001213900-20-027008","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001213900-20-027008","line_url":"/filing/0001213900-20-027008","is_derivative":false,"issuer_cik":"0000352998","issuer_name":"Teligent, Inc.","issuer_ticker":"TLGT","issuer_name_source":null,"issuer_url":"/issuer/0000352998","owner_cik":null,"owner_name":"MORRIS BEN T; GALE JAMES C; WEIR DONALD V; LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP; LIFE SCIENCES OPPORTUNITIES FUND II LP; SANDERS DON A; SIGNET HEALTHCARE PARTNERS, LLC","owner_display_name":"MORRIS BEN T","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":1.13253712,"price_display":"1.13","price_state":"stated","total_value":113253.712,"total_display":"113,253.71","total_whole":"113,254","shares_owned_after":573902.0,"shares_owned_after_display":"573,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-25","filed_date":"2020-09-16","scope":"insider","n_lines":2},{"id":2885809,"accession":"0001213900-20-027008","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-20-027008","line_url":"/filing/0001213900-20-027008","is_derivative":false,"issuer_cik":"0000352998","issuer_name":"Teligent, Inc.","issuer_ticker":"TLGT","issuer_name_source":null,"issuer_url":"/issuer/0000352998","owner_cik":null,"owner_name":"MORRIS BEN T; GALE JAMES C; WEIR DONALD V; LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP; LIFE SCIENCES OPPORTUNITIES FUND II LP; SANDERS DON A; SIGNET HEALTHCARE PARTNERS, LLC","owner_display_name":"MORRIS BEN T","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":121394.0,"shares_display":"121,394","price_per_share":1.660801553618795,"price_display":"1.66","price_state":"stated","total_value":201611.3438,"total_display":"201,611.34","total_whole":"201,611","shares_owned_after":658718.0,"shares_owned_after_display":"658,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-21","filed_date":"2020-09-16","scope":"insider","n_lines":2},{"id":2885800,"accession":"0001213900-20-027008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-20-027008","line_url":"/filing/0001213900-20-027008","is_derivative":false,"issuer_cik":"0000352998","issuer_name":"Teligent, Inc.","issuer_ticker":"TLGT","issuer_name_source":null,"issuer_url":"/issuer/0000352998","owner_cik":null,"owner_name":"MORRIS BEN T; GALE JAMES C; WEIR DONALD V; LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP; LIFE SCIENCES OPPORTUNITIES FUND II LP; SANDERS DON A; SIGNET HEALTHCARE PARTNERS, LLC","owner_display_name":"MORRIS BEN T","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87271.0,"shares_display":"87,271","price_per_share":2.254890523770783,"price_display":"2.25","price_state":"stated","total_value":196786.5509,"total_display":"196,786.55","total_whole":"196,787","shares_owned_after":761680.0,"shares_owned_after_display":"761,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-19","filed_date":"2020-09-16","scope":"insider","n_lines":2},{"id":8147433,"accession":"0001214659-15-002044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-15-002044","line_url":"/filing/0001214659-15-002044","is_derivative":false,"issuer_cik":"0000352998","issuer_name":"IGI LABORATORIES, INC","issuer_ticker":"IG","issuer_name_source":null,"issuer_url":"/issuer/0000352998","owner_cik":null,"owner_name":"GALE JAMES C; LIFE SCIENCES OPPORTUNITIES FUND II LP; LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP; MORRIS BEN T; SANDERS DON A; SIGNET HEALTHCARE PARTNERS, LLC","owner_display_name":"GALE JAMES C","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000000.0,"shares_display":"2,000,000","price_per_share":9.95,"price_display":"9.95","price_state":"stated","total_value":19900000.0,"total_display":"19,900,000.00","total_whole":"19,900,000","shares_owned_after":8356988.0,"shares_owned_after_display":"8,356,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-05","filed_date":"2015-03-06","scope":"insider","n_lines":2},{"id":6965387,"accession":"0001181431-14-031047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-031047","line_url":"/filing/0001181431-14-031047","is_derivative":false,"issuer_cik":"0000352998","issuer_name":"IGI LABORATORIES, INC","issuer_ticker":"IG","issuer_name_source":null,"issuer_url":"/issuer/0000352998","owner_cik":null,"owner_name":"LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP; LOF PARTNERS LLC; SANDERS DON A; MORRIS BENJAMIN T; GALE JAMES C; LIFE SCIENCES OPPORTUNITIES FUND II LP","owner_display_name":"LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000000.0,"shares_display":"2,000,000","price_per_share":6.45,"price_display":"6.45","price_state":"stated","total_value":12900000.0,"total_display":"12,900,000.00","total_whole":"12,900,000","shares_owned_after":10053308.0,"shares_owned_after_display":"10,053,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider","n_lines":2},{"id":6257433,"accession":"0001181431-14-030520","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-030520","line_url":"/filing/0001181431-14-030520","is_derivative":false,"issuer_cik":"0000352998","issuer_name":"IGI LABORATORIES, INC","issuer_ticker":"IG","issuer_name_source":null,"issuer_url":"/issuer/0000352998","owner_cik":null,"owner_name":"LIFE SCIENCES OPPORTUNITIES FUND II LP; LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP; LOF PARTNERS LLC; MORRIS BENJAMIN T; SANDERS DON A; GALE JAMES C","owner_display_name":"LIFE SCIENCES OPPORTUNITIES FUND II LP","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000000.0,"shares_display":"3,000,000","price_per_share":6.2,"price_display":"6.20","price_state":"stated","total_value":18600000.0,"total_display":"18,600,000.00","total_whole":"18,600,000","shares_owned_after":11749808.0,"shares_owned_after_display":"11,749,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-27","filed_date":"2014-08-29","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000352998","name":"Teligent, Inc.","url":"/issuer/0000352998","role":"Ten percent owner, Other","n_filings":4,"first_seen":"2014-08-29","last_seen":"2020-09-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001280952","retrieved_at":"2026-08-22T16:19:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}